JENNIFER CAMPOLI: Open Payments
NPI 1205201530 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,979 in 41 payments from 25 companies in 2025. Trend: 2023 $941 · 2024 $609 · 2025 $1,979
Food & beverage: $1,310Consulting: $570Education: $99
| Company | Payments | Amount |
|---|---|---|
| Legend Biotech USA Inc. | 1 | $570 |
| Janssen Biotech, Inc. | 4 | $340 |
| Gilead Sciences, Inc. | 3 | $142 |
| GENZYME CORPORATION | 2 | $140 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $65 |
| JAZZ PHARMACEUTICALS INC. | 2 | $62 |
| Daiichi Sankyo Inc. | 2 | $57 |
| BeOne Medicines USA, Inc. | 2 | $54 |
| Genentech USA, Inc. | 2 | $51 |
Products named: CARVYKTI, RYBREVANT, Trodelvy, SARCLISA, ENHERTU, OPDIVO, ZEPZELCA, BRUKINSA.
Industry payments across DE — which companies pay providers there.
